Side Effects: Possible nausea, constipation, or diarrhea, generally mild and temporary
Discussion COVID-19 is a viral infection of the respiratory system 5, 13,14
Decisions about any permanent Medicare GLP-1 coverage framework will need to incorporate geriatric-specific guidance that the current demonstration program has not addressed
CagriSema Side Effects & Safety CagriSema's tolerability profile is dominated by gastrointestinal events, consistent with the GLP-1 receptor agonist class and amylin pathway literature
Because these policies have changed over time, patients should review the most current FDA guidance and ask their prescriber or pharmacy how their product is sourced and compounded
Taga M, Minett T, Classey J, et al